Medullary thyroid carcinoma showing melanocytic differentiation: A report of a rare case

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Medullary thyroid carcinoma (MTC) accounts for 5-10% of all thyroid malignancies. These tumors show variable morphological features; however, to the best of our knowledge, melanocytic differentiation is rare with only 11 reported cases. We report a 44-year-old female who presented to our clinic with neck swelling of a few months. The thyroid fne needle aspiration biopsy results were suspicious, leading to a total thyroidectomy. On microscopic examination, a malignant tumor with melanocytic features was seen. There was no amyloid deposition in the stroma. Immunohistochemical analysis revealed that the tumor cells were positive for calcitonin, melan-A, HMB45, pancytokeratin, chromogranin, carcinoembriyonic antigen; focal positive for S-100; and negative for HBME-1 and thyroglobulin. This tumor was diagnosed as medullary carcinoma with melanocytic differentiation when evaluated with the morphological and immunohistochemical findings.

Cite

CITATION STYLE

APA

Karaarslan, S., Ertan, Y., Buğdaycı, M. H., Taşlı, F., Ören, D., & Akalın, T. (2015). Medullary thyroid carcinoma showing melanocytic differentiation: A report of a rare case. Turkish Journal of Endocrinology and Metabolism, 19(2), 72–75. https://doi.org/10.4274/tjem.2630

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free